Evaluation of the Positron Emission Tomography (PET) Tracer ZK 6032924 in Patients With Multiple Sclerosis Compared to Healthy Volunteers

NCT01031199 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Positron-Emission Tomography
Multiple Sclerosis

Interventions

DRUG: F-18 FEDAA1106 (BAY85-8101)
DRUG: F-18 FEDAA1106 (BAY85-8101)

Sponsor

Bayer